News About: Pharm. Affairs


KPDS, “There is nothing to worry about side effects of Glivec generics”

Since concerns have been raised over the side effects of Glivec generics, a pharmacists’ association made an official opinion, “There is nothing to be concerned of.” The Korean Pharmacists for Democratic Society(KPDS...

‘Basaglar,’ price-competitive biosimilar, launched in Korea

‘Basaglar,’ the first insulin glargine biosimilar in Korea, will be launched. Lilly Korea and Boehringer Ingelheim Korea held a meeting to celebrate the launch of ‘Basaglar(generic name: insulin glargine 100U/ml),’ a...

“Keywords for success of biosimilars are quality differentiation and tailored strategy by country”

Experts evaluated success of biosimilars depends on quality differentiation and tailored strategy by country. Moreover, it anticipated Europe leads the biosimilar market now, but the U.S. will take the leadership wit...

Celltrion applies sales approval of Herzuma to enter Japanese market

Celltrion announced it applied sales approval of Herzuma(CT-P6, generic name: trastuzumab), a self-developed anticancer antibody biosimilar, at the Japanese Ministry of Health, Labour and Welfare on the 11th to enter ...

Competition among Olive Young, Watsons and LOHB’s over KRW 1.3 trillion market

Korean H&B(Health & Beauty) stores, like Olive Young, Watsons and LOHB’s, had made a fierce competition, which created a market of KRW 1.3 trillion last year. 3 H&B stores, such as Olive Young Watsons and LOHB’s, war...

Will ‘Public Health Scholarship System’ revive?

While the problem of medical manpower shortage in medically vulnerable areas continues to be suggested, the public health scholarship system will be pushed forward to generate public health personnel. The Minjoo Part...

Increasing No. of pharmaceutical products suspended of advertising for exaggeration and slandering

There is an increasing number of pharmaceutical products receiving administrative measures for exaggerated, overstated and slandering advertisements. According to the Ministry of Food and Drug Safety(MFDS), administr...

KPTA establishes bridgehead to expand into U.S. pharmaceutical market

The Korea Pharmaceutical Traders Association(KPTA) was evaluated that it has established a bridgehead for Korean pharmaceutical companies to expand their business into the U.S. pharmaceutical market as recently holdin...

Bukwang Pharm signs exclusive sales agreement of schizophrenia treatment ‘lurasidone’

Bukwang Pharm announced it signed an exclusive license agreement od development, marketing, sales and distribution in Korea for ‘lurasidone’ developed by Sumitomo Dainippon Phar...

Power of the automatic ordering system combining pharmacy claim programs

The industry has shown interests in changes related to the automated ordering system combining pharmacy claim programs. PharmOrder, a service CreSoty has started, has attracted pharmacies and pharmaceutical distribut...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.